These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3276413)

  • 1. Effect of captopril and other inhibitors of angiotensin-converting enzyme on plasma prolidase activity.
    Myara I; Cosson C; Plouin PF; Moatti N
    Clin Chem; 1988 Jan; 34(1):172-3. PubMed ID: 3276413
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts.
    Karna E; Szoka L; Palka JA
    Pharmazie; 2010 Aug; 65(8):614-7. PubMed ID: 20824963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat and human prolidases by captopril.
    Ganapathy V; Pashley SJ; Roesel RA; Pashley DH; Leibach FH
    Biochem Pharmacol; 1985 Apr; 34(8):1287-91. PubMed ID: 3888225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test].
    Vernigora AN; Gengin MT; Nikishin NN; Shchetinina NV
    Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
    Banks RJ; Mozley L; Dourish CT
    Neuroscience; 1994 Feb; 58(4):799-805. PubMed ID: 8190257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K; Andersson RG
    Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
    Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
    Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the inhibitory activity of angiotensin-converting enzyme inhibitor captopril by high performance capillary electrophoresis].
    Xin ZH; Ma HL; Wu SY; Dai CH
    Yao Xue Xue Bao; 2003 Nov; 38(11):843-5. PubMed ID: 14991998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
    Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
    Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release.
    Richardt G; Kranzhöfer R; Schömig A
    Eur Heart J; 1991 Dec; 12 Suppl F():121-3. PubMed ID: 1804631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
    Mira ML; Silva MM; Queirós MJ; Manso C
    Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction.
    Flores-Monroy J; Ferrario CM; Valencia-Hernández I; Hernández-Campos ME; Martínez-Aguilar L
    Pharmacology; 2014; 94(1-2):21-8. PubMed ID: 25171296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril prevention project--what shall we do about captopril and the risk of stroke?
    Fournier A; Pruna A; Esper NE; Makdassi R; Oprisiu R; Westeel PF; Mazouz H; Achard JM
    Nephrol Dial Transplant; 2000 Jan; 15(1):2-5. PubMed ID: 10607758
    [No Abstract]   [Full Text] [Related]  

  • 16. Orally administered angiotensin-converting enzyme-inhibitors captopril and isoleucine-proline-proline have distinct effects on local renin-angiotensin system and corticosterone synthesis in dextran sulfate sodium-induced colitis in mice.
    Salmenkari H; Holappa M; Forsgard RA; Korpela R; Vapaatalo H
    J Physiol Pharmacol; 2017 Jun; 68(3):355-362. PubMed ID: 28820392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts.
    Szoka L; Karna E; Morka RP; Palka JA
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):677-83. PubMed ID: 25772062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril caused a far lesser reduction in serum angiotensin-converting enzyme (ACE).
    Pedersen HD; Koch J
    J Vet Intern Med; 1999; 13(1):76-7. PubMed ID: 10052068
    [No Abstract]   [Full Text] [Related]  

  • 19. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
    van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.